NYGC logo
NYGC logo for sticky header
Our Policies
Terms & Conditions
Privacy Policy
Careers
Contact Us
Support Us
close
Careers
Contact Us
Support Us
About Us
About Us
About Us
Our People
Our Commitment to Diversity, Equity, and Inclusion
Our Donors
Our Facility
Member Institutions
close
Research Areas
Research Areas
All Research Areas
Cancer
Computational Genomics
COVID-19 Genomics
Genomic Technologies
Neurodegenerative Disease
Neuropsychiatric Disease
close
Labs
Labs
All Labs
Faculty Labs
Center for Genomics of Neurodegenerative Disease – Phatnani Lab
Gürsoy Lab
Imieliński Lab
Iossifov Lab
Knowles Lab
Landau Lab
Lappalainen Lab
Sanjana Lab
Satija Lab
Singh Lab
Vicković Lab
Wigler Lab
Zhu Lab
NYGC Labs
Clinical Lab
Computational Biology Lab / Bioinformatics
Research Sequencing
Technology Innovation Lab
close
Publications
News
Events
Partner with Us
Partner with Us
Collaborative Research
Affiliate Membership Program
Research Sequencing
Industry & Foundation Collaborations
Academic Collaborations
Disease-specific Consortia
Tech Transfer
Sponsored Research
Clinical Lab
close
Search
close
Print
Identification of targetable BRAF ΔN486_P490 variant by whole genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma.
